Literature DB >> 18971279

Genetic history of hepatitis C virus in East Asia.

Oliver G Pybus1, Eleanor Barnes, Rachel Taggart, Philippe Lemey, Peter V Markov, Bouachan Rasachak, Bounkong Syhavong, Rattanaphone Phetsouvanah, Isabelle Sheridan, Isla S Humphreys, Ling Lu, Paul N Newton, Paul Klenerman.   

Abstract

The hepatitis C virus (HCV), which currently infects an estimated 3% of people worldwide, has been present in some human populations for several centuries, notably HCV genotypes 1 and 2 in West Africa and genotype 6 in Southeast Asia. Here we use newly developed methods of sequence analysis to conduct the first comprehensive investigation of the epidemic and evolutionary history of HCV in Asia. Our analysis includes new HCV core (n = 16) and NS5B (n = 14) gene sequences, obtained from serum samples of jaundiced patients from Laos. These exceptionally diverse isolates were analyzed in conjunction with all available reference strains using phylogenetic and Bayesian coalescent methods. We performed statistical tests of phylogeographic structure and applied a recently developed "relaxed molecular clock" approach to HCV for the first time, which indicated an unexpectedly high degree of rate variation. Our results reveal a >1,000-year-long development of genotype 6 in Asia, characterized by substantial phylogeographic structure and two distinct phases of epidemic history, before and during the 20th century. We conclude that HCV lineages representing preexisting and spatially restricted strains were involved in multiple, independent local epidemics during the 20th century. Our analysis explains the generation and maintenance of HCV diversity in Asia and could provide a template for further investigations of HCV spread in other regions.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18971279      PMCID: PMC2612398          DOI: 10.1128/JVI.01501-08

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  62 in total

1.  Prevalence and genotype of hepatitis C virus infection in pregnant women and blood donors in Ghana.

Authors:  M H Wansbrough-Jones; E Frimpong; B Cant; K Harris; M R Evans; C G Teo
Journal:  Trans R Soc Trop Med Hyg       Date:  1998 Sep-Oct       Impact factor: 2.184

2.  Evidence for high genetic diversity and long-term endemicity of hepatitis C virus genotypes 1 and 2 in West Africa.

Authors:  D Jeannel; C Fretz; Y Traore; N Kohdjo; A Bigot; E Pê Gamy; G Jourdan; K Kourouma; G Maertens; F Fumoux; J J Fournel; L Stuyver
Journal:  J Med Virol       Date:  1998-06       Impact factor: 2.327

3.  Identification of shared populations of human immunodeficiency virus type 1 infecting microglia and tissue macrophages outside the central nervous system.

Authors:  T H Wang; Y K Donaldson; R P Brettle; J E Bell; P Simmonds
Journal:  J Virol       Date:  2001-12       Impact factor: 5.103

4.  Hepatitis C virus variants from Jakarta, Indonesia classifiable into novel genotypes in the second (2e and 2f), tenth (10a) and eleventh (11a) genetic groups.

Authors:  H Tokita; H Okamoto; H Iizuka; J Kishimoto; F Tsuda; L A Lesmana; Y Miyakawa; M Mayumi
Journal:  J Gen Virol       Date:  1996-02       Impact factor: 3.891

5.  Invasion and maintenance of dengue virus type 2 and type 4 in the Americas.

Authors:  Christine V F Carrington; Jerome E Foster; Oliver G Pybus; Shannon N Bennett; Edward C Holmes
Journal:  J Virol       Date:  2005-12       Impact factor: 5.103

6.  The epidemic behavior of the hepatitis C virus.

Authors:  O G Pybus; M A Charleston; S Gupta; A Rambaut; E C Holmes; P H Harvey
Journal:  Science       Date:  2001-06-22       Impact factor: 47.728

7.  Seroprevalence of hepatitis B and C virus infections among Lao blood donors.

Authors:  Prapan Jutavijittum; Amnat Yousukh; Bounthome Samountry; Khamtim Samountry; Angkham Ounavong; Te Thammavong; Jerapha Keokhamphue; Kan Toriyama
Journal:  Southeast Asian J Trop Med Public Health       Date:  2007-07       Impact factor: 0.267

8.  Hepatitis C virus variants from Thailand classifiable into five novel genotypes in the sixth (6b), seventh (7c, 7d) and ninth (9b, 9c) major genetic groups.

Authors:  H Tokita; H Okamoto; P Luengrojanakul; K Vareesangthip; T Chainuvati; H Iizuka; F Tsuda; Y Miyakawa; M Mayumi
Journal:  J Gen Virol       Date:  1995-09       Impact factor: 3.891

Review 9.  Genetic diversity and evolution of hepatitis C virus--15 years on.

Authors:  Peter Simmonds
Journal:  J Gen Virol       Date:  2004-11       Impact factor: 3.891

10.  Heterogeneity of hepatitis C virus genotype 2 variants in West Central Africa (Guinea Conakry).

Authors:  A Ruggieri; C Argentini; F Kouruma; P Chionne; E D'Ugo; E Spada; S Dettori; S Sabbatani; M Rapicetta
Journal:  J Gen Virol       Date:  1996-09       Impact factor: 3.891

View more
  95 in total

Review 1.  Hepatitis C virus genotype 6: virology, epidemiology, genetic variation and clinical implication.

Authors:  Vo Duy Thong; Srunthron Akkarathamrongsin; Kittiyod Poovorawan; Pisit Tangkijvanich; Yong Poovorawan
Journal:  World J Gastroenterol       Date:  2014-03-21       Impact factor: 5.742

2.  HCV Genotype 6 Increased the Risk for Hepatocellular Carcinoma Among Asian Patients With Liver Cirrhosis.

Authors:  Mei-Hsuan Lee; Tiffany I Hsiao; Shreenidhi R Subramaniam; An K Le; Vinh D Vu; Huy N Trinh; Jian Zhang; Mingjuan Jin; Vincent Wai-Sun Wong; Grace Lai-Hung Wong; Mindie H Nguyen
Journal:  Am J Gastroenterol       Date:  2017-04-25       Impact factor: 10.864

3.  A panel of 16 full-length HCV genomes was characterized in China belonging to genotypes 1-6 including subtype 2f and two novel genotype 6 variants.

Authors:  Ru Xu; Wangxia Tong; Lin Gu; Chunhua Li; Yongshui Fu; Ling Lu
Journal:  Infect Genet Evol       Date:  2013-09-05       Impact factor: 3.342

4.  Impact of Preexisting Hepatitis C Virus Genotype 6 NS3, NS5A, and NS5B Polymorphisms on the In Vitro Potency of Direct-Acting Antiviral Agents.

Authors:  Fiona McPhee; Joseph Ueland; Vincent Vellucci; Scott Bowden; William Sievert; Nannan Zhou
Journal:  Antimicrob Agents Chemother       Date:  2019-03-27       Impact factor: 5.191

5.  Characterization of a canine homolog of hepatitis C virus.

Authors:  Amit Kapoor; Peter Simmonds; Gisa Gerold; Natasha Qaisar; Komal Jain; Jose A Henriquez; Cadhla Firth; David L Hirschberg; Charles M Rice; Shelly Shields; W Ian Lipkin
Journal:  Proc Natl Acad Sci U S A       Date:  2011-05-24       Impact factor: 11.205

Review 6.  Hepatitis C.

Authors:  Daniel P Webster; Paul Klenerman; Geoffrey M Dusheiko
Journal:  Lancet       Date:  2015-02-14       Impact factor: 79.321

7.  Historical Trends in the Hepatitis C Virus Epidemics in North America and Australia.

Authors:  Chaturaka Rodrigo; Auda A Eltahla; Rowena A Bull; Jason Grebely; Gregory J Dore; Tanya Applegate; Kimberly Page; Julie Bruneau; Meghan D Morris; Andrea L Cox; William Osburn; Arthur Y Kim; Janke Schinkel; Naglaa H Shoukry; Georg M Lauer; Lisa Maher; Margaret Hellard; Maria Prins; Chris Estes; Homie Razavi; Andrew R Lloyd; Fabio Luciani
Journal:  J Infect Dis       Date:  2016-08-28       Impact factor: 5.226

8.  The evolution of the major hepatitis C genotypes correlates with clinical response to interferon therapy.

Authors:  Phillip S Pang; Paul J Planet; Jeffrey S Glenn
Journal:  PLoS One       Date:  2009-08-11       Impact factor: 3.240

9.  Viral phylodynamics and the search for an 'effective number of infections'.

Authors:  Simon D W Frost; Erik M Volz
Journal:  Philos Trans R Soc Lond B Biol Sci       Date:  2010-06-27       Impact factor: 6.237

10.  The infective causes of hepatitis and jaundice amongst hospitalised patients in Vientiane, Laos.

Authors:  Bounkong Syhavong; Bouachanh Rasachack; Lee Smythe; Jean-Marc Rolain; Anne-Marie Roque-Afonso; Kemajittra Jenjaroen; Vimone Soukkhaserm; Simmaly Phongmany; Rattanaphone Phetsouvanh; Sune Soukkhaserm; Te Thammavong; Mayfong Mayxay; Stuart D Blacksell; Eleanor Barnes; Philippe Parola; Elisabeth Dussaix; Didier Raoult; Isla Humphreys; Paul Klenerman; Nicholas J White; Paul N Newton
Journal:  Trans R Soc Trop Med Hyg       Date:  2010-04-07       Impact factor: 2.184

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.